{
  "image_filename": "table_p2_1737bcc6.png",
  "image_path": "FlublokPI/extracted/figures/table_p2_1737bcc6.png",
  "claim_id": "claim_000",
  "claim": "Flublok is approved for adults 18 years and older",
  "supports_claim": false,
  "explanation": "The image is a table of solicited local and systemic adverse event rates for two influenza vaccines (Flublok, N=972, and IIV3, N=967). It lists percentages for pain, redness, headache, fatigue, etc., but it does not include any information about the age of the study participants or an approval age range. There is no mention in the table of an 18-year-old or older population or any label indicating that Flublok is approved specifically for adults aged 18 years and older.",
  "model_used": "o4-mini"
}